

Cyanocobalamin, cobalamin
Vitamin B-12 refers to the group of compounds that consists of cyanocobalamin, hydroxocobalamin, and related substances and is part of the vitamin B-complex family. It is essential for normal nerve function, DNA synthesis, hematopoiesis, fatty acid metabolism, and amino acid synthesis in the mitochondria. It also plays an important role in the metabolism of homocysteine and the synthesis of S-adenosylmethionine. Vitamin B-12 is naturally synthesized by bacteria and is abundant in diets that include meat and dairy products. Following oral intake, it is absorbed in the intestine after binding to intrinsic factor that is secreted in the stomach. Deficiency can occur in patients who have malabsorption syndromes and in people who follow a strict vegetarian diet. Lack of B-12 can lead to a wide variety of hematologic, neurologic, and psychiatric disorders and may increase the risk of cardiovascular diseases (11).
Low serum B-12 level has been associated with increased bone turnover and fracture risk (1).
Repletion of vitamin B-12 may improve response in patients resistant to antidepressants (19).
When used as homocysteine-lowering therapy, vitamin B-12, folate, and vitamin B-6 may have cardiovascular benefits after coronary interventions (13). However, increased risk of in-stent restenosis with such treatment has been reported in patients after coronary stenting (8). Vitamin B-12 supplementation as part of the homocysteine-lowering therapy does not improve cognitive function (2) (5) (9) (21).
Clinical studies show increased intake of vitamin B-12 together with folate and vitamin B-6 may lower the risk of breast cancer (7) (15) (16) and cervical cancer (4), but has no effect on the risk of lung cancer (3). Findings from another study indicate that a combination of folate and vitamins B6 and B12 did not have an effect on overall risk of invasive cancer or breast cancer (17). However, recent data suggest higher cancer incidence and mortality in patients with ischemic heart disease following supplementation with vitamin B12 and folic acid (18). Further studies are needed to confirm these findings in other populations.
Supplementation with vitamin B-12 and folic acid reduces the toxicity of Pemetrexed, a chemotherapeutic agent, in patients with non-small cell lung cancer (NSCLC) (20).
Vitamin B-12 is involved in the transfer of methyl groups and methylation reactions essential for the synthesis of phospholipids and neurotransmitters in the CNS. B-12 is also required for the synthesis of nucleic acid, notably DNA, and the metabolism of fatty acids and amino acids in the mitochondria (2). In humans, two enzymatic reactions are dependent on B-12. Vitamin B-12 functions as a coenzyme in a methyl transfer reaction that converts homocysteine to methionine. B-12 also participates in the reaction that converts L-methylmalonyl-coenzyme A (CoA) to succinyl-CoA (11). In the first enzyme reaction methylcobalamin is used to recycle the folate cofactor 5-methyltetrahydrofolate to tetrahydrofolate thereby, allowing the folate cofactor to participate in a cycle involving the biosynthesis of purines, pyrimidines. During this reaction, homocysteine is converted to methionine yielding the methyl groups required for methylation that is essential for biosynthesis (14).
AbsorptionThe acidic environment of the stomach facilitates the release of B-12 that is bound to food. The parietal cells of the stomach release intrinsic factor which binds to the vitamin in the duodenum. The vitamin B-12/Intrinsic factor complex assists the absorption of B-12 in the terminal ileum. Evidence supports the existence of a second avenue of absorption that does not rely on intrinsic factor or an intact ileum. As much as 1% of a large oral dose of B-12 is absorbed by this secondary mechanism (11). Drugs that reduce gastric intrinsic factor secretion can also reduce the absorption of B-12. Patients with pernicious anemia are not able to produce intrinsic factor and cannot absorb vitamin B-12 orally.
Distribution
Once absorbed, B-12 is bound to transcobalamin II and is distributed throughout the body with the largest amount taken up in the liver (11).
Metabolism/Excretion
Approximately 0.1% of body stores of B-12 are lost per day with equal amounts excreted through the digestive and urinary tracts (14).
Vitamin B-12 may increase the risk of in-stent restenosis in patients after coronary stenting (8).
Geissbuhler P, Mermillod B, Rapin CH. Elevated serum vitamin B12 levels associated with CRP as a predictive factor of mortality in palliative care cancer patients: a prospective study over five years. J Pain Symptom Management 2000;20(2):93-103.
One hundred and sixty-one patients were recruited between 1988 and 1989 with an average age of 74.7 years. Survival length decreased with increasing serum B-12 levels (P=0.0015, Cox model) The data presented indicate that elevated serum vitamin B-12 levels are a predictive factor for mortality in terminally ill cancer patients independent of other important prognostic factors such as C-reactive protein (CRP). The authors suggest a new prognostic index multiplying serum B-12 by CRP as easier to use and less expensive than the PINI model employed presently.
Eussen SJ, de Groot LC, Joosten LW, et al. Effect of oral vitamin B-12 with or without folic acid on cognitive function in older people with mild vitamin B-12 deficiency: a randomized, placebo-controlled trial. Am J Clin Nutr 2006;84(2):361-70.
In this-study, 195 participants with mild B-12 deficiency aged >=70 years were assigned to receive 1000mcg vitamin B-12, 1000mcg B-12 plus 400mcg folic acid, or placebo for 24 weeks. Cognitive function was assessed before and after treatment using a neuropsychological test battery including domains of attention, construction, sensomotor speed and memory. Memory function improved in the placebo group more so than in the group who only received B-12 (P = 0.0036). Neither B-12 supplementation alone, or in combination with folic acid, showed any improvement in cognitive function in test subjects after 24 weeks.
Zhang SM, Willett WC, Selhub J, et al. Plasma folate, vitamin B-6, vitamin B-12, homocysteine, and risk of breast cancer. J Natl Cancer Inst 2003;95(5):373-80.
In this prospective nested case-control study within the Nurse's Health Study, 32,826 women had blood samples obtained in 1989 and 1990 and were followed through 1996 for the development of breast cancer. 712 breast cancer patients and 712 matched controls were identified. Higher levels of plasma folate were associated with lower breast cancer risk especially in women with moderate alcohol consumption. (>= 15g/day) and in post menopausal women. Pre-menopausal women with the highest plasma B-12 levels also have lower breast cancer risk. The authors conclude that their findings suggest a chemopreventive role in breast cancer for folate and B-6 may contribute to a reduction in risk of breast cancer.
Bottom Line: Vitamin B-12, in combination with folate and vitamin B-6, may reduce breast cancer risk.
Vitamin B-12 is involved in synthesis of phospholipids, neurotransmitters, DNA, and the metabolism of fatty acids and amino acids in the cells. It is found in meat, fish, dairy products and fortified cereal. Drugs that reduce stomach acid secretion or production of intrinsic factor can reduce the absorption of B-12. High levels of folic acid intake may mask a B-12 deficiency.
Patients should discuss supplement use with their physicians.
Improving Cognitive functionA randomized placebo-controlled clinical trial found neither B-12 supplementation alone or in combination with folate showed any improvement in cognitive function.
Breast Cancer Prevention
In a prospective case-control study within the Nurse's Health Study, higher levels of plasma folate were found to associate with lower breast cancer risk especially in women with moderate alcohol consumption and in post menopausal women. Pre-menopausal women with the highest plasma B-12 levels also have lower breast cancer risk. The findings suggest a chemopreventive role in breast cancer for folate and B-6 and that food rich in folate and B-6 may contribute to a reduction in risk of breast cancer.
Medication that reduces stomach acid and intrinsic factor production may decrease the absorption of vitamin B-12.